Search For "nasal spray"
Understanding the Causes and Symptoms of Allergic Rhinitis
Updated : 1 year, 1 month ago IST
New Delhi [India], January 31: Allergic rhinitis is a very common condition often termed as hay fever, which affects millions of people globally. This chronic condition arises from the reaction of the immune system to allergens like pollen, dust mites, mold, or animal dander. Although it's n
Read More
Snoring, breathing difficulties in children can be reduced by simple nasal
Updated : 3 years, 2 months ago IST
According to a new study, a simple nasal spray significantly reduced snoring and breathing difficulties in children and halved the number needing to have their tonsils removed.
Read More
Simple nasal spray significantly reduces snoring and breathing difficultie
Updated : 3 years, 2 months ago IST
A simple nasal spray significantly reduced snoring and breathing difficulties in children and halved the number needing to have their tonsils removed, according to a new study.
Read More
Nasal spray might help with sleep apnea: Study
Updated : 3 years, 3 months ago IST
A medication in development for obstructive sleep apnoea (OSA) showed promising results after being tested in humans for the first time by Flinders University researchers.
Read More
Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in t
Updated : 3 years, 6 months ago IST
London [UK]/ Mahwah (New Jersey) [US], Mumbai (Maharashtra) [India], August 31 (ANI/PRNewswire): Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) - an innovation driven gl
Read More
Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trial
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Read More
Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) - a global, innovation-driven pharmaceutical company and Canadian pharmaceutical company SaNOtize Research & Development Corp., today announced launch of its Nitric Oxide Nasal Spray un
Read More
First nasal spray for treating adult COVID-19 patients launched in India
Updated : 4 years, 1 month ago IST
New Delhi [India], February 9 (ANI): Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.
Read More
Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclu
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Lot
Read More
Glenmark's subsidiary receives NDA Approval by US FDA for Ryaltris™
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark Specialty S.A. (Switzerland), received FDA approval on its New Drug Application (NDA) fo
Read More
Glenmark receives marketing approval for Ryaltris®, an innovative com
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris® in 13 countries across the EU and UK.
Read More
Glenmark receives marketing approval for Ryaltris in 13 countries across E
Updated : 4 years, 5 months ago IST
New Delhi [India] September 30 (ANI): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris in 13 countries across the EU and UK.
Read More